1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 956 F.Supp.2d
  5. 956 F.Supp.2d 295 (2013)
 

MOMENTA PHARMACEUTICALS v. TEVA PHARMACEUTICALS

Civil Action No. 10-12079-NMG.

956 F.Supp.2d 295 (2013)

MOMENTA PHARMACEUTICALS, INC., Sandoz Inc., Plaintiffs, v. TEVA PHARMACEUTICALS USA, INC., Defendant.

United States District Court, D. Massachusetts.

July 19, 2013.

Attorney(s) appearing for the Case

Robert S. Frank, Jr., Daniel C. Winston, Eric J. Marandett, Jessica Gan Lee, Michael E. Murawski, Sophie F. Wang, Choate, Hall & Stewart, Sarah Chapin Columbia, Melissa Nott Davis, McDermott, Will & Emery LLP, Boston, MA, Thomas P. Steindler, McDermott Will & Emery LLP, Washington, DC, for Plaintiffs.

Daniel B. Reagan, David M. Hashmall, Joshua A. Whitehill, Goodwin Procter LLP, New York, NY, Elaine Herrmann Blais, James Rehnquist, Robert Frederickson, III, Goodwin Procter LLP, Boston, MA, for Defendant.

G. Mark Edgarton, Choate, Hall & Stewart, Boston, MA.

MEMORANDUM & ORDER

GORTON, District Judge.

Plaintiffs Momenta Pharmaceuticals, Inc. and Sandoz Inc. (collectively, "Momenta") bring suit against Teva Pharmaceuticals USA, Inc. ("Teva") for infringement of U.S. Patent No. 7,575,886 ("the '886 patent").1

I. Background

In July, 2010, after receiving FDA approval, plaintiffs began to market...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases